Oren Gilad
Vermogen: 329 335 $ op 31-05-2026
Vermogen: 329 335 $ op 31-05-2026
Oren Gilad was the founder of Atrin Pharmaceuticals LLC, founded in 2011, where the title held was President, Chief Executive Officer & Director.
Dr. Gilad was also the founder of Atrin Pharmaceuticals, Inc., founded in 2011, where the title held was President & Chief Executive Officer from 2011 to 2022.
Currently, Dr. Gilad holds the position of President, Chief Executive Officer & Director at Aprea Therapeutics, Inc., starting in 2022.
The education history includes a doctorate from the University of Pennsylvania, a doctorate from the University of California, Davis, and an undergraduate degree from The Hebrew University of Jerusalem.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-04-2026 | 368.796 ( 2,98% ) | 329 335 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| APREA THERAPEUTICS, INC. | Algemeen Directeur | 29-06-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Algemeen Directeur | 01-01-2022 |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 6 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Health Technology |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau